What Does the Street Have to Say About Bristol-Myers Squibb Company (BMY)?

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best immunotherapy stocks to buy according to hedge funds. Bristol-Myers Squibb Company (NYSE:BMY) announced on February 12 plans to become an inaugural partner to Life Science Cares in support of its national campaign in fighting food insecurity. Management reported that the Food is Health: Nourishing Communities, Advancing Health initiative, led by Life Science Cares, aims to invest $30 million and mobilize 30,000 volunteer hours by 2030 to deliver a ...